Unknown PHASE1 INTERVENTIONAL 3-arm NCT02731092

Safety and Tolerability of Lactoferrin in Very Low Birth Weight Infants

Sponsor: The Gerber Foundation

Conditions Very Low Birth Weight Infants

Interventions Lactoferrin

Updated 6 times since 2017 Last updated: Apr 18, 2016 Started: Apr 30, 2016 Primary completion: Dec 31, 2016 Completion: Mar 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Very Low Birth Weight Infants and is currently ongoing. The Gerber Foundation leads this study, which shows 6 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1
May 2018 — Jun 2018 [monthly]

Unknown Status PHASE1

Status: Recruiting → Unknown Status

▶ Show 1 earlier version

Jan 2017 — May 2018 [monthly]

Recruiting PHASE1

First recorded

Apr 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The Gerber Foundation
University of Virginia

Data source: University of Virginia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Charlottesville, United States